Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.
Black Diamond Therapeutics is a medical company focused on analyzing genetically defined cancers.
Cerebral Therapeutics is a clinical-stage pharmaceutical company.
Nuvation Bio is a global biopharmaceutical company focusing on unmet needs in oncology.
Absci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the therapeutic potential of proteins
Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.
Marea is a biotechnology company that develops therapies and medications for the treatment of cardioendocrine illness patients.
Neuron23 is a developer of drugs intended to treat Parkinson's disease and Alzheimer's disease.
SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.
Zentalis is a pharmaceutical company focused on developing clinical therapeutics for cancer patients.
Mereo is a new UK-based speciality biopharmaceutical company.
Orchestra BioMed is a biomedical innovation company that provides high-impact solutions for large unmet needs in procedure-based medicine.
Apogee Therapeutics is a biotechnology company that offers therapies for immunological and inflammatory disorders.
A-Alpha Bio uses synthetic biology and machine learning to measure, discover, predict, and engineer protein-protein interactions.
Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.
CinDome Pharma provides treatment for the millions of people living with the devastating impact of chronic gastroparesis.
Imperative Care is singularly dedicated to finding meaningful answers to unsolved problems in stroke.
Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.
Outlook Therapeutics is a biopharmaceutical company that develops ophthalmic formulations.
Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.
Beam Therapeutics is a biotechnology company developing precision genetic medicines through the use of base editing technology.
Talkiatry provides virtual mental healthcare services covered by insurance, connecting patients with licensed psychiatrists.
Xilio Therapeutics is a biotechnology company that develops tumor-activated immuno-oncology therapies.
Nautilus Biotechnology is a life sciences company that develops a platform for analyzing and quantifying the human proteome.
Perceptive Advisors has invested in 225 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Perceptive Advisors's top investment sectors include Biotechnology, Health Care, Medical, Life Science, Therapeutics. The firm invests across 19 different industry categories.
Among tracked funding rounds, Apogee Therapeutics received $1.3B in a Post-IPO Debt round. Perceptive Advisors's total known invested capital is $29.6B.
Perceptive Advisors's average investment size is $156.7M across its portfolio of 225 companies.
Recent Perceptive Advisors portfolio additions include 4D Molecular Therapeutics, Black Diamond Therapeutics, Cerebral Therapeutics, Nuvation Bio, Absci. These companies were founded in 2020 or later.